Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.
Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Int J Mol Sci. 2023 Sep 7;24(18):13809. doi: 10.3390/ijms241813809.
Whole-exome sequencing (WES) in families with an unexplained tendency for venous thromboembolism (VTE) may favor detection of low-frequency variants in genes with known contribution to hemostasis or associated with VTE-related phenotypes. WES analysis in six family members, three of whom affected by documented VTE, filtered for MAF < 0.04 in 192 candidate genes, revealed 22 heterozygous (16 missense and six synonymous) variants in patients. Functional prediction by multi-component bioinformatics tools, implemented by a database/literature search, including ClinVar annotation and QTL analysis, prioritized 12 missense variants, three of which ( Leu61Pro, Asn514Lys and Arg139Trp) were present in all patients, and the frequent functional variants Arg478Lys and Ala114Ser. Combinations of prioritized variants in each patient were used to infer functional protein interactions. Different interaction patterns, supported by high-quality evidence, included eight proteins intertwined in the "acute phase" (CRP, F2, SERPINA1 and IL1A) and/or in the "fibrinogen complex" (CRP, F2, PLAT, THBS1, VWF and FGB) significantly enriched terms. In a wide group of candidate genes, this approach highlighted six low-frequency variants ( Leu61Pro, Asn514Lys, Arg63Cys, Asp901Glu, Arg1399His and Arg164Trp), five of which were top ranked for predicted deleteriousness, which in different combinations may contribute to disease susceptibility in members of this family.
全外显子组测序(WES)在不明原因静脉血栓栓塞(VTE)倾向的家族中可能有利于检测已知与止血相关或与 VTE 相关表型相关的基因中的低频变异。对 6 名家庭成员进行 WES 分析,其中 3 名受记录的 VTE 影响,在 192 个候选基因中筛选出 MAF < 0.04 的变异,在患者中发现 22 个杂合(16 个错义和 6 个同义)变异。通过数据库/文献搜索实施的多组件生物信息学工具的功能预测,包括 ClinVar 注释和 QTL 分析,优先考虑了 12 个错义变异,其中 3 个(Leu61Pro、Asn514Lys 和 Arg139Trp)存在于所有患者中,以及常见的功能变异 Arg478Lys 和 Ala114Ser。每位患者优先错义变异的组合用于推断功能蛋白相互作用。不同的相互作用模式,由高质量的证据支持,包括在“急性期”(CRP、F2、SERPINA1 和 IL1A)和/或在“纤维蛋白原复合物”(CRP、F2、PLAT、THBS1、VWF 和 FGB)中交织的八个蛋白显著富集的术语。在广泛的候选基因组中,这种方法突出了六个低频变异(Leu61Pro、Asn514Lys、Arg63Cys、Asp901Glu、Arg1399His 和 Arg164Trp),其中五个是预测有害性的最高排名,它们以不同的组合可能导致该家族成员易患疾病。